(AGYS) Agilysys - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US00847J1051
Stock: Software, Cloud, POS, Management
Total Rating 37
Risk 92
Buy Signal -0.26
| Risk 5d forecast | |
|---|---|
| Volatility | 45.2% |
| Relative Tail Risk | -3.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -24.16 |
| Character TTM | |
|---|---|
| Beta | 1.051 |
| Beta Downside | 1.096 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.61% |
| CAGR/Max DD | -0.07 |
EPS (Earnings per Share)
Revenue
Description: AGYS Agilysys March 04, 2026
Agilysys, Inc. (AGYS) develops and markets software solutions and services for the hospitality industry. This sector includes hotels, resorts, and food and beverage establishments. The companys offerings span property management systems, point-of-sale (POS) solutions, and inventory/procurement tools.
Their business model focuses on providing integrated software, cloud applications, and professional services. Key products include the InfoGenesis POS and various property management systems like LMS and Stay. Many companies in the application software sub-industry generate recurring revenue through subscriptions and maintenance contracts.
Agilysys also offers specialized solutions for enhanced guest experiences, such as self-service kiosks and digital menu boards, reflecting a trend towards automation in hospitality. Further research on platforms like ValueRay can provide deeper insights into their market position and financial performance.
Headlines to watch out for
- Hospitality industry recovery drives software demand
- Cloud subscription growth boosts recurring revenue
- New product adoption expands market share
- Labor costs impact professional services margins
- Competition intensifies from integrated solution providers
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 30.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 0.01 > 1.0 |
| NWC/Revenue: 12.84% < 20% (prev 6.17%; Δ 6.67% < -1%) |
| CFO/TA 0.13 > 3% & CFO 61.3m > Net Income 30.4m |
| Net Debt (-46.3m) to EBITDA (49.4m): -0.94 < 3 |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.4m) vs 12m ago 0.44% < -2% |
| Gross Margin: 60.88% > 18% (prev 0.63%; Δ 6.03k% > 0.5%) |
| Asset Turnover: 67.60% > 50% (prev 59.38%; Δ 8.22% > 0%) |
| Interest Coverage Ratio: 55.21 > 6 (EBITDA TTM 49.4m / Interest Expense TTM 716k) |
Altman Z'' 3.64
| A: 0.08 (Total Current Assets 169.8m - Total Current Liabilities 129.9m) / Total Assets 475.2m |
| B: 0.39 (Retained Earnings 187.5m / Total Assets 475.2m) |
| C: 0.09 (EBIT TTM 39.5m / Avg Total Assets 459.5m) |
| D: 1.17 (Book Value of Equity 189.0m / Total Liabilities 162.1m) |
| Altman-Z'' Score: 3.64 = AA |
Beneish M -2.89
| DSRI: 1.12 (Receivables 70.1m/53.3m, Revenue 310.6m/263.6m) |
| GMI: 1.03 (GM 60.88% / 62.68%) |
| AQI: 0.92 (AQ_t 0.58 / AQ_t-1 0.63) |
| SGI: 1.18 (Revenue 310.6m / 263.6m) |
| TATA: -0.07 (NI 30.4m - CFO 61.3m) / TA 475.2m) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of AGYS shares?
As of March 21, 2026, the stock is trading at USD 70.81 with a total of 533,592 shares traded.
Over the past week, the price has changed by +3.39%, over one month by -9.96%, over three months by -42.30% and over the past year by -5.70%.
Over the past week, the price has changed by +3.39%, over one month by -9.96%, over three months by -42.30% and over the past year by -5.70%.
Is AGYS a buy, sell or hold?
Agilysys has received a consensus analysts rating of 4.80.
Therefore, it is recommended to buy AGYS.
- StrongBuy: 4
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AGYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 138 | 94.9% |
| Analysts Target Price | 138 | 94.9% |
AGYS Fundamental Data Overview March 16, 2026
P/E Trailing = 64.0093
P/E Forward = 31.9489
P/S = 6.1974
P/B = 6.1473
P/EG = 4.8092
Revenue TTM = 310.6m USD
EBIT TTM = 39.5m USD
EBITDA TTM = 49.4m USD
Long Term Debt = 24.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 5.42m USD (from shortTermDebt, last quarter)
Debt = 35.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -46.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.88b USD (1.93b + Debt 35.2m - CCE 81.5m)
Interest Coverage Ratio = 55.21 (Ebit TTM 39.5m / Interest Expense TTM 716k)
EV/FCF = 31.74x (Enterprise Value 1.88b / FCF TTM 59.2m)
FCF Yield = 3.15% (FCF TTM 59.2m / Enterprise Value 1.88b)
FCF Margin = 19.05% (FCF TTM 59.2m / Revenue TTM 310.6m)
Net Margin = 9.79% (Net Income TTM 30.4m / Revenue TTM 310.6m)
Gross Margin = 60.88% ((Revenue TTM 310.6m - Cost of Revenue TTM 121.5m) / Revenue TTM)
Gross Margin QoQ = 59.48% (prev 61.75%)
Tobins Q-Ratio = 3.95 (Enterprise Value 1.88b / Total Assets 475.2m)
Interest Expense / Debt = 0.09% (Interest Expense 30.0k / Debt 35.2m)
Taxrate = 23.18% (2.99m / 12.9m)
NOPAT = 30.4m (EBIT 39.5m * (1 - 23.18%))
Current Ratio = 1.31 (Total Current Assets 169.8m / Total Current Liabilities 129.9m)
Debt / Equity = 0.11 (Debt 35.2m / totalStockholderEquity, last quarter 313.1m)
Debt / EBITDA = -0.94 (Net Debt -46.3m / EBITDA 49.4m)
Debt / FCF = -0.78 (Net Debt -46.3m / FCF TTM 59.2m)
Total Stockholder Equity = 289.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.62% (Net Income 30.4m / Total Assets 475.2m)
RoE = 10.50% (Net Income TTM 30.4m / Total Stockholder Equity 289.7m)
RoCE = 12.60% (EBIT 39.5m / Capital Employed (Equity 289.7m + L.T.Debt 24.0m))
RoIC = 10.17% (NOPAT 30.4m / Invested Capital 298.7m)
WACC = 9.62% (E(1.93b)/V(1.96b) * Re(9.79%) + D(35.2m)/V(1.96b) * Rd(0.09%) * (1-Tc(0.23)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.67%
[DCF] Terminal Value 76.20% ; FCFF base≈57.6m ; Y1≈71.1m ; Y5≈121.0m
[DCF] Fair Price = 56.36 (EV 1.54b - Net Debt -46.3m = Equity 1.58b / Shares 28.1m; r=9.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 57.25 | EPS CAGR: 16.09% | SUE: -0.26 | # QB: 0
Revenue Correlation: 99.56 | Revenue CAGR: 15.68% | SUE: 0.62 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.44 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=6
EPS next Year (2027-03-31): EPS=2.17 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+31.4% | Growth Revenue=+14.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.2% (Discount Rate 9.8% - Earnings Yield 1.6%)
[Growth] Growth Spread = +3.5% (Analyst 11.7% - Implied 8.2%)
P/E Forward = 31.9489
P/S = 6.1974
P/B = 6.1473
P/EG = 4.8092
Revenue TTM = 310.6m USD
EBIT TTM = 39.5m USD
EBITDA TTM = 49.4m USD
Long Term Debt = 24.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 5.42m USD (from shortTermDebt, last quarter)
Debt = 35.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -46.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.88b USD (1.93b + Debt 35.2m - CCE 81.5m)
Interest Coverage Ratio = 55.21 (Ebit TTM 39.5m / Interest Expense TTM 716k)
EV/FCF = 31.74x (Enterprise Value 1.88b / FCF TTM 59.2m)
FCF Yield = 3.15% (FCF TTM 59.2m / Enterprise Value 1.88b)
FCF Margin = 19.05% (FCF TTM 59.2m / Revenue TTM 310.6m)
Net Margin = 9.79% (Net Income TTM 30.4m / Revenue TTM 310.6m)
Gross Margin = 60.88% ((Revenue TTM 310.6m - Cost of Revenue TTM 121.5m) / Revenue TTM)
Gross Margin QoQ = 59.48% (prev 61.75%)
Tobins Q-Ratio = 3.95 (Enterprise Value 1.88b / Total Assets 475.2m)
Interest Expense / Debt = 0.09% (Interest Expense 30.0k / Debt 35.2m)
Taxrate = 23.18% (2.99m / 12.9m)
NOPAT = 30.4m (EBIT 39.5m * (1 - 23.18%))
Current Ratio = 1.31 (Total Current Assets 169.8m / Total Current Liabilities 129.9m)
Debt / Equity = 0.11 (Debt 35.2m / totalStockholderEquity, last quarter 313.1m)
Debt / EBITDA = -0.94 (Net Debt -46.3m / EBITDA 49.4m)
Debt / FCF = -0.78 (Net Debt -46.3m / FCF TTM 59.2m)
Total Stockholder Equity = 289.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.62% (Net Income 30.4m / Total Assets 475.2m)
RoE = 10.50% (Net Income TTM 30.4m / Total Stockholder Equity 289.7m)
RoCE = 12.60% (EBIT 39.5m / Capital Employed (Equity 289.7m + L.T.Debt 24.0m))
RoIC = 10.17% (NOPAT 30.4m / Invested Capital 298.7m)
WACC = 9.62% (E(1.93b)/V(1.96b) * Re(9.79%) + D(35.2m)/V(1.96b) * Rd(0.09%) * (1-Tc(0.23)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.67%
[DCF] Terminal Value 76.20% ; FCFF base≈57.6m ; Y1≈71.1m ; Y5≈121.0m
[DCF] Fair Price = 56.36 (EV 1.54b - Net Debt -46.3m = Equity 1.58b / Shares 28.1m; r=9.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 57.25 | EPS CAGR: 16.09% | SUE: -0.26 | # QB: 0
Revenue Correlation: 99.56 | Revenue CAGR: 15.68% | SUE: 0.62 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.44 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=6
EPS next Year (2027-03-31): EPS=2.17 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+31.4% | Growth Revenue=+14.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.2% (Discount Rate 9.8% - Earnings Yield 1.6%)
[Growth] Growth Spread = +3.5% (Analyst 11.7% - Implied 8.2%)